Erratum to: Long-term control of diabetes in immunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine islets (Am J Transplant, (2015), 15, (2837-2850), 10.1111/ajt.13345);Long-term control of diabetes in immunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine islets

American Journal of Transplantation

Volumn 15, Issue 11, 2015, Pages 2837-2850

  Shin, J S ^a   Kim, J M ^a   Kim, J S ^a   Min, B H ^a   Kim, Y H ^a   Kim, H J ^a   Jang, J Y ^a   Yoon, I H ^a   Kang, H J ^b   Kim, J ^a   Hwang, E S ^a   Lim, D G ^c   Lee, W W ^a   Ha, J ^a   Jung, K C ^a   Park, S H ^a   Kim, S J ^a,d   Park, C G ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c National Medical Centre   (South Korea)

^d Myong ji Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CD28 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; COBROTOXIN; GLUCOSE; RAPAMYCIN; THYMOCYTE ANTIBODY;

ADOPTIVE TRANSFER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; DIABETES CONTROL; EX VIVO STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS GLUCOSE TOLERANCE TEST; LOW DRUG DOSE; MALE; MINIPIG; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PRIMATE; PRIORITY JOURNAL; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; RHESUS MONKEY; ANALYSIS OF VARIANCE; ANIMAL; DIABETES MELLITUS, TYPE 1; DISEASE MODEL; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; NEEDLE BIOPSY; NONPARAMETRIC TEST; PIG; PROCEDURES; TRANSPLANTATION CONDITIONING; XENOGRAFT;

ANALYSIS OF VARIANCE; ANIMALS; BIOPSY, NEEDLE; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS TRANSPLANTATION; MACACA MULATTA; MALE; SIROLIMUS; STATISTICS, NONPARAMETRIC; SWINE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HETEROLOGOUS;

EID: 84945480505     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13861     Document Type: Erratum

References (40)

1. Marigliano M, Bertera S, Grupillo M, Trucco M, Bottino R,. Pig-to-nonhuman primates pancreatic islet xenotransplantation: An overview. Curr Diab Rep 2011; 11: 402-412.
2. Mandel TE,. Fetal islet xenotransplantation in rodents and primates. J Mol Med 1999; 77: 155-160.
3. Hering BJ, Wijkstrom M, Graham ML, et al., Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006; 12: 301-303.
4. Cardona K, Korbutt GS, Milas Z, et al., Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12: 304-306.
5. Hering BJ, Cooper DK, Cozzi E, et al., The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes- executive summary. Xenotransplantation 2009; 16: 196-202.
6. Cooper DK, Casu A,. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-chapter 4: Pre-clinical efficacy and complication data required to justify a clinical trial. Xenotransplantation 2009; 16: 229-238.
7. Cooper DK, Bottino R, Satyananda V, Wijkstrom M, Trucco M,. Toward clinical islet xenotransplantation-Are revisions to the IXA guidelines warranted? Xenotransplantation 2013; 20: 68-74.
8. Wijkstrom M, Bottino R, Cooper DK,. Limitations of the pig-to-non-human primate islet transplantation model. Xenotransplantation 2013; 20: 2-4.
9. van der Windt DJ, Bottino R, Kumar G, et al., Clinical islet xenotransplantation: How close are we? Diabetes 2012; 61: 3046-3055.
10. van der Windt DJ, Bottino R, Casu A, et al., Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 2009; 9: 2716-2726.
11. Jin SM, Shin JS, Kim KS, et al., Islet isolation from adult designated pathogen-free pigs: Use of the newer bovine nervous tissue-free enzymes and a revised donor selection strategy would improve the islet graft function. Xenotransplantation 2011; 18: 369-379.
12. Kim HI, Lee SY, Jin SM, et al., Parameters for successful pig islet isolation as determined using 68 specific-pathogen-free miniature pigs. Xenotransplantation 2009; 16: 11-18.
13. Jin SM, Kim KS, Lee SY, et al., The sequential combination of a JNK inhibitor and simvastatin protects porcine islets from peritransplant apoptosis and inflammation. Cell Transplant 2011; 20: 1139-1151.
14. Park YH, Koo SK, Kim Y, et al., Effect of in vitroexpanded CD4(+)CD25(+) Foxp3(+) regulatory T cell therapy combined with lymphodepletion in murine skin allotransplantation. Clin Immunol 2010; 135: 43-54.
15. Jung KC, Park CG, Jeon YK, et al., In situ induction of dendritic cell-based T cell tolerance in humanized mice and nonhuman primates. J Exp Med 2011; 208: 2477-2488.
16. Kang HJ, Lee H, Ha JM, et al., The role of the alternative complement pathway in early graft loss after intraportal porcine islet xenotransplantation. Transplantation 2014; 97: 999-1008.
17. Lockridge KM, Sequar G, Zhou SS, Yue Y, Mandell CP, Barry PA,. Pathogenesis of experimental rhesus cytomegalovirus infection. J Virol 1999; 73: 9576-9583.
18. Lee EB, Kwon YJ, Shin KC, et al., Decreased serum level of antibody against human cytomegalovirus in patients with Behcet's disease. Rheumatol Int 2005; 25: 33-36.
19. van der Windt DJ, Bottino R, Casu A, Campanile N, Cooper DK,. Rapid loss of intraportally transplanted islets: An overview of pathophysiology and preventive strategies. Xenotransplantation 2007; 14: 288-297.
20. Casu A, Bottino R, Balamurugan AN, et al., Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: Implications for translation into clinical practice. Diabetologia 2008; 51: 120-129.
21. Cardona K, Milas Z, Strobert E, et al., Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant 2007; 7: 2260-2268.
22. Thompson P, Badell IR, Lowe M, et al., Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. Am J Transplant 2011; 11: 2593-2602.
23. Thompson P, Badell IR, Lowe M, et al., Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival. Am J Transplant 2012; 12: 1765-1775.
24. Buhler L, Deng S, O'Neil J, et al., Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation 2002; 9: 3-13.
25. Rood PP, Bottino R, Balamurugan AN, et al., Reduction of early graft loss after intraportal porcine islet transplantation in monkeys. Transplantation 2007; 83: 202-210.
26. D'Addio F, Yuan X, Habicht A, et al., A novel clinically relevant approach to tip the balance toward regulation in stringent transplant model. Transplantation 2010; 90: 260-269.
27. Ciubotariu R, Colovai AI, Pennesi G, et al., Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28- regulatory T cells. J Immunol 1998; 161: 5193-5202.
28. Guillonneau C, Picarda E, Anegon I,. CD8+ regulatory T cells in solid organ transplantation. Curr Opin Organ Transplant 2010; 15: 751-756.
29. Kirk AD, Burkly LC, Batty DS, et al., Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5: 686-693.
30. Thompson P, Cardona K, Russell M, et al., CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant 2011; 11: 947-957.
31. Imai A, Suzuki T, Sugitani A, et al., A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys. Transplantation 2007; 84: 1020-1028.
32. Oura T, Yamashita K, Suzuki T, et al., Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates. Am J Transplant 2012; 12: 1740-1754.
33. Watanabe M, Yamashita K, Suzuki T, et al., ASKP1240, a fully human Anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates. Am J Transplant 2013; 13: 1976-1988.
34. Goldwater R, Keirns J, Blahunka P, et al., A phase 1, randomized ascending single-dose study of antagonist anti-human CD40 ASKP1240 in healthy subjects. Am J Transplant 2013; 13: 1040-1046.
35. Wakefield I, Peters C, Burkly L, et al., CDP7657, a monovalent fab PEG anti-CD40L antibody, inhibits immune responses in both HuSCID mice and non-human primates. Arthritis Rheum 2010; 62 (Suppl. 10): 1245.
36. Cochrane CG, Muller-Eberhard HJ, Aikin BS,. Depletion of plasma complement in vivo by a protein of cobra venom: Its effect on various immunologic reactions. J Immunol 1970; 105: 55-69.
37. Vogel CW, Finnegan PW, Fritzinger DC,. Humanized cobra venom factor: Structure, activity, and therapeutic efficacy in preclinical disease models. Mol Immunol 2014; 61: 191-203.
38. Bottino R, Wijkstrom M, van der Windt DJ, et al., Pig-to-monkey islet xenotransplantation using multi-transgenic pigs. Am J Transplant 2014; 14: 2275-2287.
39. 6th Collaborative Islet Transplant Registry (CITR) Annual Report. CITR Coordinating Center. The EMMES Corporation, Rockville, MD, 2009.
40. Gala-Lopez B, Pepper AR, Shapiro AM,. Biologic agents in islet transplantation. Curr Diab Rep 2013; 13: 713-722.